|
Comera Life Sciences Holdings Inc (CMRA) |
|
Comera Life Sciences Holdings Inc
CMRA's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Comera Life Sciences Holdings Inc 's sales fell
by -41.98 % in III. Quarter 2023 from the same quarter a year ago.
Ranking at No. 3049
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -4.75 %
Comera Life Sciences Holdings Inc net loss decreased from $-3 millions, to $-2 millions in III. Quarter 2023,
• More on CMRA's Growth
|
|
Comera Life Sciences Holdings Inc realized a net loss in trailing twelve months.
Comera Life Sciences Holdings Inc realized cash reduction of $ -0.04 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.47.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.77.
• More on CMRA's Valuation
|
|
|
|
|
Comera Life Sciences Holdings Inc realized net loss in trailing twelve months.
Comera Life Sciences Holdings Inc realized cash outflow of $ -0.04per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.47.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.77.
• More on CMRA's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com